Posters
Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data
Presenting Author Academic/Professional Position
Aura Calderon
Academic Level (Author 1)
Resident
Discipline/Specialty (Author 1)
Internal Medicine
Academic Level (Author 2)
Resident
Discipline/Specialty (Author 2)
Internal Medicine
Academic Level (Author 3)
Resident
Discipline/Specialty (Author 3)
Internal Medicine
Academic Level (Author 4)
Resident
Discipline/Specialty (Author 4)
Internal Medicine
Academic Level (Author 5)
Faculty
Discipline/Specialty (Author 5)
Internal Medicine
Discipline Track
Clinical Science
Abstract Type
Research/Clinical
Abstract
Background: Cervical carcinoma continues to exert a disproportionate burden on Hispanic women within the United States, notably in jurisdictions such as Texas, where individuals of Hispanic descent constitute more than 40% of the demographic populace. Notwithstanding progress in screening methodologies and preventive measures, considerable disparities persist in incidence rates, mortality figures, and survival outcomes when assessed through the lens of racial and ethnic stratifications.
Objective: To examine and visually communicate disparities in cervical cancer burden among Hispanic women through a combination of national survival data and Texas state-level incidence and mortality statistics.
Methods: Publicly accessible datasets were employed from the SEER program (2000–2021) and the 2024 Texas Cervical Cancer Data Brief. Tailored data visualizations were created to analyze cervical cancer incidence, mortality, and survival stratified by age, stage at diagnosis, and race/ethnicity. The analysis underscored longitudinal survival trends and disparities specific to states.
Results: Incidence and Mortality in Texas: Within the state of Texas, Hispanic women exhibited the highest incidence rate of cervical carcinoma (12.0 per 100,000) from 2017 to 2021, surpassing all other racial and ethnic populations. The mortality rates remained significantly elevated at 3.2 per 100,000, ranking second only to those observed among Non-Hispanic Black women.
Survival by Stage at Diagnosis: Prolonged survival rates were profoundly influenced by the stage at which the diagnosis was made. Women identified at a localized stage demonstrated an impressive 10-year survival rate exceeding 87%, whereas those diagnosed at a distant stage faced survival rates falling below 14%.
Age-Related Outcomes: Relative survival rates exhibited an inverse correlation with advancing age. Women aged over 65 years experienced a significant decline in survival over time in comparison to their younger counterparts, highlighting the vulnerabilities associated with aging.
Ethnic Survival Differences: Hispanic women demonstrated marginally improved 5- and 10-year survival rates compared to certain minority groups (e.g., Non-Hispanic Black women), yet they lagged behind Non-Hispanic Whites and Asian/Pacific Islanders, thereby indicating persistent disparities in health outcomes despite the implementation of similar access initiatives.
Conclusion: The inequitable prevalence of cervical cancer among Hispanic women in Texas highlights the critical necessity for screening programs that are both culturally sensitive and readily accessible. In light of the state's demographic realities and the survival disadvantages associated with late-stage diagnoses, interventions must emphasize early detection, comprehensive patient education, and equitable provision of healthcare services. This investigation underscores the significance of state-level cancer surveillance and the implementation of targeted policy initiatives aimed at eradicating health disparities in cervical cancer outcomes. Proposed strategies may encompass the expansion of HPV vaccination initiatives, the enhancement of Pap smear accessibility in regions with elevated risk, and the incorporation of community-focused educational programs tailored for Hispanic populations.
Presentation Type
Poster
Recommended Citation
Calderon, Aura M. C.; Mogollon, Ivan; Goyal, Shubhank; Loayza, Jose; Cobos, Everardo; and Nguyen, Diane, "Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data" (2025). Research Colloquium. 17.
https://scholarworks.utrgv.edu/colloquium/2025/posters/17
Included in
Cervical Cancer Disparities in Hispanic Women: A Multilevel Analysis Using SEER and Texas State Data
Background: Cervical carcinoma continues to exert a disproportionate burden on Hispanic women within the United States, notably in jurisdictions such as Texas, where individuals of Hispanic descent constitute more than 40% of the demographic populace. Notwithstanding progress in screening methodologies and preventive measures, considerable disparities persist in incidence rates, mortality figures, and survival outcomes when assessed through the lens of racial and ethnic stratifications.
Objective: To examine and visually communicate disparities in cervical cancer burden among Hispanic women through a combination of national survival data and Texas state-level incidence and mortality statistics.
Methods: Publicly accessible datasets were employed from the SEER program (2000–2021) and the 2024 Texas Cervical Cancer Data Brief. Tailored data visualizations were created to analyze cervical cancer incidence, mortality, and survival stratified by age, stage at diagnosis, and race/ethnicity. The analysis underscored longitudinal survival trends and disparities specific to states.
Results: Incidence and Mortality in Texas: Within the state of Texas, Hispanic women exhibited the highest incidence rate of cervical carcinoma (12.0 per 100,000) from 2017 to 2021, surpassing all other racial and ethnic populations. The mortality rates remained significantly elevated at 3.2 per 100,000, ranking second only to those observed among Non-Hispanic Black women.
Survival by Stage at Diagnosis: Prolonged survival rates were profoundly influenced by the stage at which the diagnosis was made. Women identified at a localized stage demonstrated an impressive 10-year survival rate exceeding 87%, whereas those diagnosed at a distant stage faced survival rates falling below 14%.
Age-Related Outcomes: Relative survival rates exhibited an inverse correlation with advancing age. Women aged over 65 years experienced a significant decline in survival over time in comparison to their younger counterparts, highlighting the vulnerabilities associated with aging.
Ethnic Survival Differences: Hispanic women demonstrated marginally improved 5- and 10-year survival rates compared to certain minority groups (e.g., Non-Hispanic Black women), yet they lagged behind Non-Hispanic Whites and Asian/Pacific Islanders, thereby indicating persistent disparities in health outcomes despite the implementation of similar access initiatives.
Conclusion: The inequitable prevalence of cervical cancer among Hispanic women in Texas highlights the critical necessity for screening programs that are both culturally sensitive and readily accessible. In light of the state's demographic realities and the survival disadvantages associated with late-stage diagnoses, interventions must emphasize early detection, comprehensive patient education, and equitable provision of healthcare services. This investigation underscores the significance of state-level cancer surveillance and the implementation of targeted policy initiatives aimed at eradicating health disparities in cervical cancer outcomes. Proposed strategies may encompass the expansion of HPV vaccination initiatives, the enhancement of Pap smear accessibility in regions with elevated risk, and the incorporation of community-focused educational programs tailored for Hispanic populations.
